Skip to main content
. Author manuscript; available in PMC: 2014 Oct 30.
Published in final edited form as: Leukemia. 2013 Jan 23;27(7):1487–1496. doi: 10.1038/leu.2013.23

Figure 1. FMH9 cells and AML cells flow cytometric characterisation.

Figure 1

(a) (b) Staining with labelled antibodies against stem cell-related antigens (KIT, SCA-1, CD34, FLT3) and lineage specific markers (GR-1, CD11b) are overlaid against matched isotype controls. (c) FLT3 mRNA quantification by quantitative-PCR, normalised against the 18S house keeping gene results.